Nuclear medicine is entering a new stage of development in Kazakhstan. Modern technologies now make it possible to detect dangerous diseases at an early stage and improve the treatment effectiveness, ...
Apollo Athenaa Cancer Conclave 2026 will bring global experts to discuss precision, evidence-based breast cancer care in ...
Live webcast of event on February 27 at 8:00 a.m. ET will include participation of globally renowned gynecological oncology KOLs from the US and EU KOL panel to discuss maturing data from the ACR-368 ...
Hamlet and Linnane are supported in the process by PharmaVentures, an international advisory firm specializing in pharmaceutical partnering and licensing transactions. The purpose of the engagement is ...
Axogen, Inc. (AXGN) 47th Annual Raymond James Institutional Investor Conference March 3, 2026 3:25 PM ESTCompany ParticipantsMichael Dale - President, ...
Boston Scientific Corporation (NYSE: BSX) will host an investor event and live webcast on Saturday, March 28, 2026, at 6:30 p ...
Breast surgery increasingly employs various autologous tissue-based techniques. While free flaps (i.e. DIEP) remain the gold standard in post-mastectomy ...
Robotic surgery has revolutionized the field of genitourinary surgery over the past two decades, providing new possibilities for precision, minimally ...
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a biotechnology company advancing a ...
Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.
Namodenoson is a highly selective A3 adenosine receptor (A3AR) agonist, which has shown a compelling safety profile and demonstrated anti-tumor activity in preclinical pancreatic cancer models. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results